World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
75
Citations
19633
World Ranking
19154
National Ranking
9549

Cosimi Ab publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Cosimi Ab sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 269 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Cosimi Ab D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Cosimi Ab sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 75 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Cancer

His primary scientific interests are in Transplantation, Immunology, Kidney, Immunosuppression and Kidney transplantation. He has researched Transplantation in several fields, including Immune tolerance and Pathology. His work on Cytotoxic T cell expands to the thematically related Immunology.

His Kidney study combines topics in areas such as T cell, Incidence, Bone marrow and Histocompatibility. His work investigates the relationship between Immunosuppression and topics such as Leukopenia that intersect with problems in Ganciclovir, Azathioprine and Prednisone. As part of the same scientific family, Cosimi Ab usually focuses on Kidney transplantation, concentrating on Urinary system and intersecting with Retrospective cohort study, Donation after cardiac death and Dialysis.

His most cited work include:

  • Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. (550 citations)
  • Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte–macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma (538 citations)
  • Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. (510 citations)

What are the main themes of his work throughout his whole career to date?

Cosimi Ab mainly focuses on Immunology, Transplantation, Kidney, Immunosuppression and Surgery. His Immunology study frequently links to related topics such as Renal allograft. His biological study spans a wide range of topics, including Gastroenterology, Urinary system and Pathology.

His study in Kidney is interdisciplinary in nature, drawing from both Multiple myeloma, Bone marrow, Histocompatibility and Urology. His study focuses on the intersection of Immunosuppression and fields such as Azathioprine with connections in the field of Prednisone. His work in Surgery addresses subjects such as Melanoma, which are connected to disciplines such as Dissection.

He most often published in these fields:

  • Immunology (48.85%)
  • Transplantation (40.84%)
  • Kidney (26.34%)

What were the highlights of his more recent work (between 2009-2019)?

  • Immunology (48.85%)
  • Kidney (26.34%)
  • Kidney transplantation (17.18%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Immunology, Kidney, Kidney transplantation, Immunosuppression and Surgery. His research investigates the connection with Immunology and areas like Haematopoiesis which intersect with concerns in Homeostasis and Alloimmunity. He combines subjects such as Hematopoietic stem cell transplantation, Renal function, End stage renal disease and Urology with his study of Kidney.

To a larger extent, Cosimi Ab studies Transplantation with the aim of understanding Kidney transplantation. Cosimi Ab studies Organ transplantation which is a part of Transplantation. His studies deal with areas such as Lung transplantation, Lung, Calcineurin, Regimen and T cell as well as Immunosuppression.

Between 2009 and 2019, his most popular works were:

  • Long-Term Results in Recipients of Combined HLA-Mismatched Kidney and Bone Marrow Transplantation Without Maintenance Immunosuppression (186 citations)
  • Mechanisms of donor-specific tolerance in recipients of haploidentical combined bone marrow/kidney transplantation. (92 citations)
  • Host Alloreactive Memory T Cells Influence Tolerance to Kidney Allografts in Nonhuman Primates (87 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Cancer

His scientific interests lie mostly in Immunology, Immunosuppression, Kidney transplantation, Kidney and Tolerance induction. Immunology and Belatacept are two areas of study in which Cosimi Ab engages in interdisciplinary work. His Immunosuppression study integrates concerns from other disciplines, such as T cell, Haematopoiesis, B-cell activating factor and Gene expression profiling.

Cosimi Ab works mostly in the field of Haematopoiesis, limiting it down to topics relating to Homeostasis and, in certain cases, Transplantation, as a part of the same area of interest. His Kidney transplantation research incorporates elements of Flow cytometry, Regulation of gene expression, Naive B cell and B cell. His Kidney research is multidisciplinary, relying on both Thrombotic microangiopathy and Bone marrow.

Best Publications

  • Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte–macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

    R Soiffer;T Lynch;M Mihm;K Jung

  • Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand.

    Kawai T;Andrews D;Colvin Rb;Sachs Dh

  • Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries.

    A B Collins;E E Schneeberger;M A Pascual;S L Saidman

  • Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys.

    T Kawai;A B Cosimi;R B Colvin;J Powelson

  • Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism.

    T R Spitzer;F Delmonico;N Tolkoff-Rubin;S McAfee

  • In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts.

    A. B. Cosimi;D. Conti;F. L. Delmonico;F. I. Preffer

  • TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTION WITH OKT3 MONOCLONAL ANTIBODY

    A. Cosimi;Robert Burton;Robert Colvin;Gideon Goldstein

  • A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients.

    Craig Haug;Robert Colvin;Francis DELMONIco;Hugh Auchincloss

  • Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections.

    Cheeseman Sh;Rubin Rh;Stewart Ja;Tolkoff-Rubin Ne

  • Glomerulopathy Associated With Cytomegalovirus Viremia in Renal Allografts

    W.P. Richardson;R.B. Colvin;S.H. Cheeseman;N.E. Tolkoff-Rubin

  • Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses.

    Y. Fudaba;T. R. Spitzer;J. Shaffer;T. Kawai

  • Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality.

    S Baid;A B Cosimi;M L Farrell;D A Schoenfeld

  • Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression.

    Gregory Jaffers;Thomas Fuller;A. Cosimi;Paul Russell

  • Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease.

    Bühler Lh;Spitzer Tr;Sykes M;Sachs Dh

  • Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3.

    Patricia Hibberd;Nina Tolkoff-Rubin;A. Cosimi;Robert Schooley

  • Long-Term Results in Recipients of Combined HLA-Mismatched Kidney and Bone Marrow Transplantation Without Maintenance Immunosuppression

    T Kawai;D. H Sachs;Ben Sprangers;T. R Spitzer

  • Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients.

    Robert Rubin;A. Cosimi;Nina Tolkoff-Rubin;Paul Russell

  • Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions.

    Calvin Day;Martin Mihm;Arthur Sober;Matthew Harris

  • Association of herpesvirus infections with T-lymphocyte-subset alterations, glomerulopathy, and opportunistic infections after renal transplantation.

    R T Schooley;M S Hirsch;R B Colvin;A B Cosimi

  • Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption.

    T. Kozlowski;A. Shimizu;D. Lambrigts;K. Yamada

Frequent Co-Authors

Robert B. Colvin
Robert B. Colvin Harvard University
Francis L. Delmonico
Francis L. Delmonico Harvard University
Nina Tolkoff-Rubin
Nina Tolkoff-Rubin Harvard University
Paul S. Russell
Paul S. Russell Harvard University
David H. Sachs
David H. Sachs Columbia University
Robert H. Rubin
Robert H. Rubin Brigham and Women's Hospital
Frederic I. Preffer
Frederic I. Preffer Harvard University
Megan Sykes
Megan Sykes Columbia University
Gilles Benichou
Gilles Benichou Harvard Medical School
Hugh Auchincloss
Hugh Auchincloss National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in Medicine is not limited to becoming a physician. Many related fields offer dynamic job prospects and are accessible through online education. For example, online pharmd programs are a flexible route for those interested in pharmacy, while working professionals can also pursue affordable academic advancement.

Another in-demand area is health information management. Accredited online schools for health information management offer programs where students learn about medical records, data management, and compliance, all vital roles in modern healthcare.

If you are interested in the administrative side of healthcare, you might ask, how much does it cost to become a medical coder? Medical coding and billing is a fast-growing field, often requiring shorter, cost-effective certification programs you can complete online.

Nursing also offers advanced online pathways. For registered nurses seeking to become nurse practitioners, cheapest fnp programs make it possible to specialize and grow in responsibility in a cost-efficient way. All of these pathways allow students to enter meaningful roles in healthcare with flexibility and competitive costs.

Best Scientists Citing Cosimi Ab

Trending Scientists

Recently Published Articles